Felipe Dias Leal
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências da Saúde
Unidade:
Faculdade de Farmácia
Departamento:
Departamento de Fármacos e Medicamentos
Formação:
-
Universidade Federal do Rio de Janeiro
Química | Doutorado | 2009 - 2015
-
Universidade Federal do Rio de Janeiro
Farmácia Industrial | Graduação | 2006 - 2008
-
Associação Brasileira de Farmacêuticos
Farmacologia | Especialização | 2006 - 2007
-
Universidade Federal do Rio de Janeiro
Farmácia | Graduação | 2002 - 2006
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
(25.00% artigos com DOI)
| Titulo | DOI | Ano |
|---|---|---|
| Hologram QSAR Models of a Series of 6-Arylquinazolin-4-Amine Inhibitors of a New Alzheimer’s Disease Target: Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase-1A Enzyme | 10.3390/ijms16035235 | 2015 |
| Detection of designer steroid methylstenbolone in -nutritional supplement- using gas chromatography and tandem mass spectrometry: Elucidation of its urinary metabolites | 10.1016/j.steroids.2012.11.009 | 2013 |
| Principal component analysis (PCA) of the fragmentation patterns of anabolic steroids by tandem mass spectrometry with electrospray ionization | 2012 | |
| Specificity and selectivity improvement in doping analysis using comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry | 2012 | |
| Detection of new urinary exemestane metabolites by gas chromatography coupled to mass spectrometry | 2011 | |
| Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry | 2011 | |
| New perspectives and recommendations for anticoagulant therapy post orthopedic surgery | 2011 | |
| Analysis of exemestane and 17b-hydroxyexemestane in human urine by gas chropatography/mass spectrometry: development and validation of a method using MO-TMS derivatives | 2010 |
Eventos:
(0.00% eventos com DOI)